课题基金 / 基金详情

Evaluation of the Role of PSA Inhibitors in the Prevention and/or Therapy of

Evaluation of the Role of PSA Inhibitors in the Prevention and/or Therapy of
PSA 抑制剂在预防和/或治疗中的作用评估
批准号:
8719550
负责人:
JOHN ISAACS
金额:
$16.34万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-01 至 2014-08-31

项目摘要

项目成果

JOHN ISAACS的其他基金

相似基金

相关文献

中文摘要
翻译
前列腺癌细胞,就像正常的前列腺分泌腔上皮细胞一样,产生非常高水平的 PSA。PSA的名字很贴切,因为它只由前列腺细胞高水平产生,而不是 由人类男性的任何其他正常组织大量产生。PSA是一种类凝乳杆菌胰蛋白酶 丝氨酸蛋白酶被广泛用作前列腺癌筛查和复发检测的生物标志物 在局部治疗之后,并跟踪对转移性疾病的系统治疗的反应。然而,PSA, 也是前列腺癌的有效治疗靶点。关注PSA作为生物标志物的作用 做了或许做了
英文摘要
Prostate cancer cells, like normal prostate secretory-luminal epithelial cells, produce very high levels of the PSA. PSA is aptly named, in that it is produced at high levels exclusively by prostate cells and is not produced in significant amounts by any other normal tissue in the human male. PSA is a chymotrypsin-like serjne protease that is used extensively as a biomarker to screen for prostate cancer, to detect recurrence following local therapies and to follow response to systemic therapies for metastatic disease. PSA, however, is also a well credentialed therapeutic target for prostate cancer. The focus on PSA's role as a biomarker has made perhaps made
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluation of the Role of PSA Inhibitors in the Prevention and/or Therapy of
  • 批准号:
    7468660
  • 项目类别:
  • 资助金额:
    $26.47万
  • 财政年份:
    2008
  • 负责人:
    JOHN ISAACS
  • 依托单位:
Evaluation of the Role of PSA Inhibitors in the Prevention and/or Therapy of
  • 批准号:
    8379604
  • 项目类别:
  • 资助金额:
    $26.95万
  • 财政年份:
    --
  • 负责人:
    JOHN ISAACS
  • 依托单位:
Evaluation of the Role of PSA Inhibitors in the Prevention and/or Therapy of
  • 批准号:
    8323089
  • 项目类别:
  • 资助金额:
    $25.65万
  • 财政年份:
    --
  • 负责人:
    JOHN ISAACS
  • 依托单位:
Evaluation of the Role of PSA Inhibitors in the Prevention and/or Therapy of
  • 批准号:
    7919415
  • 项目类别:
  • 资助金额:
    $26.49万
  • 财政年份:
    --
  • 负责人:
    JOHN ISAACS
  • 依托单位:
海外基金